Literature DB >> 15326061

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Kelly J Hunt1, Roy G Resendez, Ken Williams, Steve M Haffner, Michael P Stern.   

Abstract

BACKGROUND: To assess the utility of clinical definitions of the metabolic syndrome (MetS) to identify individuals with increased cardiovascular risk, we examined the relation between the MetS, using both the National Cholesterol Education Program (NCEP) and the World Health Organization definitions, and all-cause and cardiovascular mortality in San Antonio Heart Study participants enrolled between 1984 and 1988. METHODS AND
RESULTS: Among 2815 participants, 25 to 64 years of age at enrollment, 509 met both criteria, 197 met NCEP criteria only, and 199 met WHO criteria only. Over an average of 12.7 years, 229 deaths occurred (117 from cardiovascular disease). Moreover, in the primary prevention population of 2372 participants (ie, those without diabetes or cardiovascular disease at baseline), 132 deaths occurred (50 from cardiovascular disease). In the primary prevention population, the only significant association adjusted for age, gender, and ethnic group was between NCEP-MetS and cardiovascular mortality (hazard ratio [HR], 2.01; 95% CI, 1.13-3.57). In the general population, all-cause mortality HRs were 1.47 (95% CI, 1.13-1.92) for NCEP-MetS and 1.27 (95% CI, 0.97-1.66) for WHO-MetS. Furthermore, for cardiovascular mortality, there was evidence that gender modified the predictive ability of the MetS. For women and men, respectively, HRs for NCEP-MetS were 4.65 (95% CI, 2.35-9.21) and 1.82 (95% CI, 1.14-2.91), whereas HRs for WHO-MetS were 2.83 (95% CI, 1.55-5.17) and 1.15 (95% CI, 0.72-1.86).
CONCLUSIONS: In summary, although both definitions were predictive in the general population, the simpler NCEP definition tended to be more predictive in lower-risk subjects.

Entities:  

Mesh:

Year:  2004        PMID: 15326061     DOI: 10.1161/01.CIR.0000140762.04598.F9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  128 in total

1.  Two alarming recent statistics: the increase in the uninsured and the increased prediction of the number of persons living with diabetes.

Authors:  George A Beller
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

2.  The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity.

Authors:  Fabrice M A C Martens; Frank L J Visseren
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 4.810

Review 3.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

4.  Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome.

Authors:  Hala H Zreikat; Spencer E Harpe; Patricia W Slattum; D'arcy P Mays; Paulina A Essah; Kai I Cheang
Journal:  Metabolism       Date:  2013-11-16       Impact factor: 8.694

5.  Metabolic syndrome and endothelin-1 mediated vasoconstrictor tone in overweight/obese adults.

Authors:  Natalia G Rocha; Danielle L Templeton; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Metabolism       Date:  2014-04-18       Impact factor: 8.694

Review 6.  Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

Authors:  Rhonda M Cooper-DeHoff; Michael A Pacanowski; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

7.  Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study.

Authors:  Mark D DeBoer; Matthew J Gurka; Jessica G Woo; John A Morrison
Journal:  Diabetologia       Date:  2015-09-17       Impact factor: 10.122

8.  Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.

Authors:  T Tillin; N Forouhi; D G Johnston; P M McKeigue; N Chaturvedi; I F Godsland
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

Review 9.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

10.  Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children.

Authors:  Claudia M Toledo-Corral; Emily E Ventura; Howard N Hodis; Marc J Weigensberg; Christianne J Lane; Yanjie Li; Michael I Goran
Journal:  Atherosclerosis       Date:  2009-03-25       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.